Head Of Epidemiology And Communicable

Rediff.com » News » Head Of Epidemiology And Communicable

News for Head Of Epidemiology And Communicable

News

Govt in talks with SII for Nipah antibody, may put imports on hold

Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies for treating Nipah virus infections and is in talks with Serum......

Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far

Experts said Covishield is being produced at a much higher scale than Covaxin due to which its availability is more. IMAGE: A medic shows Covishield vaccine vials at BAPS Hospital in Surat.......

ICMR, Hyderabad co develop potential treatment for COVID-19

The Indian Council of Medical Research (ICMR) in collaboration with a Hyderabad-based biopharmaceutical company has developed 'highly purified antisera' prepared by injecting inactivated......

India would get COVID-19 vaccine by year-end: Vardhan

Union Health Minister Dr Harsh Vardhan has said that if everything goes well, India would get a vaccine against the novel coronavirus by the end of this year. Three COVID-19 vaccine candidates,......

Study comparing Covishield, Covaxin has limitations: Bharat Biotech

Raches Ella, project lead, Covid-19 vaccines at Bharat Biotech said in a series of tweets that he was ‘surprised’ that media and researchers were drawing conclusions based on non-peer......

Rediff News

Head Of Epidemiology And Communicable

News for Head Of Epidemiology And Communicable

Govt in talks with SII for Nipah antibody, may put imports on hold

Covishield comprises over 90 pc of 12.76 cr COVID vaccines administered so far

ICMR, Hyderabad co develop potential treatment for COVID-19

India would get COVID-19 vaccine by year-end: Vardhan

Study comparing Covishield, Covaxin has limitations: Bharat Biotech

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS